Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 166

Results For "NITI"

3245 News Found

Sonowal and Khandu lay foundation stone for capacity expansion at NEIAFMR
Policy | December 27, 2023

Sonowal and Khandu lay foundation stone for capacity expansion at NEIAFMR

NEIAFMR to be developed as the national hub for folk medicine


BioVaxys executes LoI for major Immunotherapeutics technology acquisition
News | December 26, 2023

BioVaxys executes LoI for major Immunotherapeutics technology acquisition

BioVaxys has been granted exclusivity while the parties work in good faith on the drafting of a definitive agreement


GenSci launches global innovation hub in Shanghai
News | December 26, 2023

GenSci launches global innovation hub in Shanghai

The establishment of the facility demonstrates the company's commitment to delivering differentiated solutions to gynecology and pediatrics challenges


AstraZeneca to acquire China's Gracell Biotechnologies for US $1.2 billion
News | December 26, 2023

AstraZeneca to acquire China's Gracell Biotechnologies for US $1.2 billion

Furthering cell therapy ambition across oncology and autoimmune diseases


Stelis Biopharma updates on receipt of consideration from Syngene
News | December 25, 2023

Stelis Biopharma updates on receipt of consideration from Syngene

Syngene has completed a payment of Rs. 158.2 crores on December 22, 2023 in addition to the initial payment of Rs. 395 crores made on December 1, 2023


Ind-Swift Laboratories receives award from World HRD Congress
News | December 25, 2023

Ind-Swift Laboratories receives award from World HRD Congress

World HRD Congress is a well-known international body of Management Studies


Bristol Myers Squibb to buy Karuna Therapeutics for US$ 14 billion
News | December 24, 2023

Bristol Myers Squibb to buy Karuna Therapeutics for US$ 14 billion

Transaction delivers KarXT, a first-in-class M1/ M4 muscarinic receptor agonist with differentiated efficacy and safety


USFDA grants priority review for Patritumab Deruxtecan in US for certain patients with EGFR-mutated non-small cell lung cancer
Drug Approval | December 23, 2023

USFDA grants priority review for Patritumab Deruxtecan in US for certain patients with EGFR-mutated non-small cell lung cancer

If approved, patritumab deruxtecan would be a first-in-class HER3 directed DXd antibody drug conjugate for these patients


Ami Organics inks MoU with a global manufacturer of electrolytes
News | December 22, 2023

Ami Organics inks MoU with a global manufacturer of electrolytes

Ami Organics will also sign an MoU with Government of Gujarat for investment amounting up to Rs 300 crores for set up of dedicated manufacturing facility for electrolytes business


Abbott India MD Vivek Kamath resigns
People | December 22, 2023

Abbott India MD Vivek Kamath resigns

His resignation would be effective from March 18, 2024